G1 Therapeutics Inc (GTHX) stock is lower by -78.70% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives GTHX stock a score of 34 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 3. GTHX's rank also includes a long-term technical score of 10. The fundamental score for GTHX is 90. In addition to the average rating from Wall Street analysts, GTHX stock has a mean target price of $32.20. This means analysts expect the stock to gain 604.60% over the next 12 months.
GTHX has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on GTHX!
G1 Therapeutics Inc (GTHX) stock is higher by 7.28% while the S&P 500 is higher by 1.79% as of 3:45 PM on Tuesday, May 17. GTHX is higher by $0.31 from the previous closing price of $4.26 on volume of 1,097,354 shares. Over the past year the S&P 500 is down -2.01% while GTHX is lower by -78.70%. GTHX lost -$4.03 per share in the over the last 12 months.
Click Here to get the full Stock Report for G1 Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
